ArticleScience (New York, N.Y.)2024

Kinase-impaired BTK mutations are susceptible to clinical-stage BTK and IKZF1/3 degrader NX-2127.

Skye Montoya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.